Jellatech, a Raleigh-based biotech company, has announced an oversubscribed Seed round with $3.5 million raised. According to the SEC filing, eight investors were involved in the equity-only funding. The company, founded by Stephanie Michelsen in 2020, is focused on protein manufacturing, creating collagen that does not need to be sourced from animals. Applications include food & beverages, healthcare, pharmaceuticals, and cosmetics, among others. Earlier this year the company announced the development of functional human collagen, which can potentially see use in tissue engineering, regenerative medicine, and 3D bioprinting, as well as research applications.